GSK recalls ranitidine products over potential carcinogen contamination
Pharmacies should stop dispensing four prescription ranitidine products supplied by GlaxoSmithKline (GSK) and should return any stock to the company, says an alert issued by the UK Medicines and…
Read Original Article: GSK recalls ranitidine products over potential carcinogen contamination »
